Pfizer, BioNTech Ask FDA to Green Light Tweaked Covid-19 Vaccine

This copy is for your personal, non-commercial use only. Distribution and use of this material are…

WSJ News Exclusive | U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients

The Biden administration is planning for an end to its practice of paying for Covid-19 shots…

Moderna Names New CFO After Hasty Departure of Predecessor

Moderna Inc. named a new finance chief roughly three months after the Covid-19 vaccine maker’s previous…

U.K. Approves Moderna’s Covid-19 Vaccine Targeted at Omicron

The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster…

Poor Demand for Its Covid Vaccine Prompts Novavax to Cut Sales Forecast

Novavax Inc. slashed its full-year revenue outlook in half on Monday, citing a lack of demand…

Moderna Profit Falls Amid Charges for Unused Covid-19 Vaccines

Moderna Inc. sales rose 9% in the second quarter, but costs tied to a surplus of…

Starbucks, Uber, CVS to Report Earnings Amid Shrinking Economy

July 30, 2022 10:00 am ET Listen to article (2 minutes) CVS Health Starbucks and Uber…

U.S. Reaches $1.74 Billion Deal With Moderna for Updated Covid-19 Shots

The Biden administration said it would spend $1.74 billion to buy 66 million doses of Moderna…

Novavax’s COVID-19 vaccine wins support from CDC advisors

Updated July 19, 2022 3:23 PM ET A Centers for Disease Control and Prevention advisory panel…

Moderna is developing two different Omicron-targeting booster shots

modern Inc. said it is developing two potential COVID-19 booster shots targeting different Omicron subvariants, citing…